119 related articles for article (PubMed ID: 36880551)
1. Effect of 3α-dihydroprogesterone and 5α-dihydroprogesterone on DCIS cells and possible impact for postmenopausal women.
Sourouni M; Götte M; Kiesel L; von Wahlde MK
Climacteric; 2023 Jun; 26(3):275-283. PubMed ID: 36880551
[TBL] [Abstract][Full Text] [Related]
2. Opposing actions of the progesterone metabolites, 5alpha-dihydroprogesterone (5alphaP) and 3alpha-dihydroprogesterone (3alphaHP) on mitosis, apoptosis, and expression of Bcl-2, Bax and p21 in human breast cell lines.
Wiebe JP; Beausoleil M; Zhang G; Cialacu V
J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):125-32. PubMed ID: 19931389
[TBL] [Abstract][Full Text] [Related]
3. Membrane 5alpha-pregnane-3,20-dione (5alphaP) receptors in MCF-7 and MCF-10A breast cancer cells are up-regulated by estradiol and 5alphaP and down-regulated by the progesterone metabolites, 3alpha-dihydroprogesterone and 20alpha-dihydroprogesterone, with associated changes in cell proliferation and detachment.
Pawlak KJ; Zhang G; Wiebe JP
J Steroid Biochem Mol Biol; 2005 Nov; 97(3):278-88. PubMed ID: 16154741
[TBL] [Abstract][Full Text] [Related]
4. Plasma membrane receptors for the cancer-regulating progesterone metabolites, 5alpha-pregnane-3,20-dione and 3alpha-hydroxy-4-pregnen-20-one in MCF-7 breast cancer cells.
Weiler PJ; Wiebe JP
Biochem Biophys Res Commun; 2000 Jun; 272(3):731-7. PubMed ID: 10860824
[TBL] [Abstract][Full Text] [Related]
5. Progesterone metabolites regulate induction, growth, and suppression of estrogen- and progesterone receptor-negative human breast cell tumors.
Wiebe JP; Zhang G; Welch I; Cadieux-Pitre HA
Breast Cancer Res; 2013 May; 15(3):R38. PubMed ID: 25927181
[TBL] [Abstract][Full Text] [Related]
6. Progesterone-induced stimulation of mammary tumorigenesis is due to the progesterone metabolite, 5α-dihydroprogesterone (5αP) and can be suppressed by the 5α-reductase inhibitor, finasteride.
Wiebe JP; Rivas MA; Mercogliano MF; Elizalde PV; Schillaci R
J Steroid Biochem Mol Biol; 2015 May; 149():27-34. PubMed ID: 25595041
[TBL] [Abstract][Full Text] [Related]
7. The 4-pregnene and 5alpha-pregnane progesterone metabolites formed in nontumorous and tumorous breast tissue have opposite effects on breast cell proliferation and adhesion.
Wiebe JP; Muzia D; Hu J; Szwajcer D; Hill SA; Seachrist JL
Cancer Res; 2000 Feb; 60(4):936-43. PubMed ID: 10706108
[TBL] [Abstract][Full Text] [Related]
8. Progesterone metabolites in breast cancer.
Wiebe JP
Endocr Relat Cancer; 2006 Sep; 13(3):717-38. PubMed ID: 16954427
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of action of the breast cancer-promoter hormone, 5α-dihydroprogesterone (5αP), involves plasma membrane-associated receptors and MAPK activation.
Wiebe JP; Pawlak KJ; Kwok A
J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):166-76. PubMed ID: 26519986
[TBL] [Abstract][Full Text] [Related]
10. Regulation of estrogen receptor (ER) levels in MCF-7 cells by progesterone metabolites.
Pawlak KJ; Wiebe JP
J Steroid Biochem Mol Biol; 2007; 107(3-5):172-9. PubMed ID: 17683929
[TBL] [Abstract][Full Text] [Related]
11. Dutasteride affects progesterone metabolizing enzyme activity/expression in human breast cell lines resulting in suppression of cell proliferation and detachment.
Wiebe JP; Souter L; Zhang G
J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):129-40. PubMed ID: 16806904
[TBL] [Abstract][Full Text] [Related]
12. The endogenous progesterone metabolite, 5a-pregnane-3,20-dione, decreases cell-substrate attachment, adhesion plaques, vinculin expression, and polymerized F-actin in MCF-7 breast cancer cells.
Wiebe JP; Muzia D
Endocrine; 2001 Oct; 16(1):7-14. PubMed ID: 11822829
[TBL] [Abstract][Full Text] [Related]
13. Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma.
Lewis MJ; Wiebe JP; Heathcote JG
BMC Cancer; 2004 Jun; 4():27. PubMed ID: 15212687
[TBL] [Abstract][Full Text] [Related]
14. Association of Circulating Progesterone With Breast Cancer Risk Among Postmenopausal Women.
Trabert B; Bauer DC; Buist DSM; Cauley JA; Falk RT; Geczik AM; Gierach GL; Hada M; Hue TF; Lacey JV; LaCroix AZ; Tice JA; Xu X; Dallal CM; Brinton LA
JAMA Netw Open; 2020 Apr; 3(4):e203645. PubMed ID: 32329771
[TBL] [Abstract][Full Text] [Related]
15. Regional distribution of cytosolic and particulate 5alpha-dihydroprogesterone 3alpha-hydroxysteroid oxidoreductases in female rat brain.
Li X; Bertics PJ; Karavolas HJ
J Steroid Biochem Mol Biol; 1997 Mar; 60(5-6):311-8. PubMed ID: 9219922
[TBL] [Abstract][Full Text] [Related]
16. Uptake of (3H)progesterone and (3H)5alpha-dihydroprogesterone by rat tissues in vivo and analysis of accumulated radioactivity: accumulation of 5alpha-dihydroprogesterone by pituitary and hypothalamic tissues.
Karavolas HJ; Hodges D; O'Brien D
Endocrinology; 1976 Jan; 98(1):164-75. PubMed ID: 765114
[TBL] [Abstract][Full Text] [Related]
17. The anti-aromatase effect of progesterone and of its natural metabolites 20alpha- and 5alpha-dihydroprogesterone in the MCF-7aro breast cancer cell line.
Pasqualini JR; Chetrite G
Anticancer Res; 2008; 28(4B):2129-33. PubMed ID: 18751385
[TBL] [Abstract][Full Text] [Related]
18. Activity and expression of progesterone metabolizing 5alpha-reductase, 20alpha-hydroxysteroid oxidoreductase and 3alpha(beta)-hydroxysteroid oxidoreductases in tumorigenic (MCF-7, MDA-MB-231, T-47D) and nontumorigenic (MCF-10A) human breast cancer cells.
Wiebe JP; Lewis MJ
BMC Cancer; 2003 Mar; 3():9. PubMed ID: 12659654
[TBL] [Abstract][Full Text] [Related]
19. Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo.
Khurana A; McKean H; Kim H; Kim SH; mcguire J; Roberts LR; Goetz MP; Shridhar V
Breast Cancer Res; 2012 Mar; 14(2):R43. PubMed ID: 22410125
[TBL] [Abstract][Full Text] [Related]
20. IL-6-mediated cross-talk between human preadipocytes and ductal carcinoma in situ in breast cancer progression.
Kim HS; Jung M; Choi SK; Woo J; Piao YJ; Hwang EH; Kim H; Kim SJ; Moon WK
J Exp Clin Cancer Res; 2018 Aug; 37(1):200. PubMed ID: 30134951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
